COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;
Clinical trial NCT04534725 · COMPLETED
Trial details
- NCT number
- NCT04534725
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-17
- Primary completion
- 2022-11-28
- Enrollment
- 441
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.